RM Global Health

www.rmgh.net

 
  • Increase font size
  • Default font size
  • Decrease font size
  • default color
  • green color
  • blue color
JA Content Slide Error: There is not any content in this category

Health Plan Services

E-mail Print PDF

Quest Diagnostics is the nation's leading provider of diagnostic testing, information and services for 50% of the physicians and hospitals in the United States and over 90 million lives covered by health plans and third-party insurers like yours. Our clients include patients, physicians, hospitals, health plans, employers and government agencies.

Quest Diagnostics: Where talent meets technology

At Quest Diagnostics, people are our greatest asset. Their knowledge and expertise offers you the following advantages:

  • 42,000 dedicated employees focused on offering a broad range of clinical laboratory testing and information services
  • Largest medical and scientific staff in the laboratory industry
  • A national network of 2,000 patient service centers to provide convenience and access to our customers
  • A national network of 35 full service laboratories and approximately 140 "rapid response" laboratories that provide testing for over 500,000 patients each night
  • A national network of more than 4,000 professional couriers and 21 aircraft

 

Our resources give our customers a substantial advantage

Our resources include:

  • The world's largest private database of clinical test results to help identify best healthcare practices across patient populations
  • Assistance in complying with HEDISĀ® reporting requirements that require laboratory results
  • Leading edge diagnostic test development through our Nichols Institute, world-renowned esoteric testing center

 

Because Quest Diagnostics offers the largest scope of service, your provider network will enjoy the following benefits:

  • Access to over 1,500 tests annually to assist in detection, diagnosis, evaluation, monitoring and treatment of medical conditions
  • Experience in performing more than 6.5 million gene-based tests annually

 

A national network of excellence

  • Over 30 years of experience in delivering quality service and innovative technology

 

 
June 15, 2007
Of the 100 cases confirmed to date in Indonesia, 80 have been fatal.

Partners

Quest Diagnostics
American Society of Anethesiologists
Abkhazia Institute
WHO
Docotors Without Borders

Alerts

 
Byetta Linked to Acute Pancreatitis Six new cases of hemorrhagic or necrotizing pancreatitis have been reported in patients using exenatide injection (Byett...
 
Why Should I Report an Adverse Drug Event? When I was in charge of the postmarketing drug safety program at the US Food and Drug Administration (FDA) in the early ...